Twinbeech Capital LP Lantheus Holdings, Inc. Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$51.07 - $68.26 $7.35 Million - $9.83 Million	-143,940 Reduced 56.96%	108,768 $6.77 Million
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $14.1 Million - $19.7 Million	252,708 New	252,708 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $11.5 Million - $13.9 Million	139,388 New	139,388 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$48.76 - $77.67 $8.56 Million - $13.6 Million	175,541 Added 240.02%	248,677 $12.7 Million
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $2.72 Million - $3.83 Million	44,331 Added 153.9%	73,136 $5.14 Million
Q2 2022 Aug 15, 2022	BUY	$55.54 - $72.65 $1.6 Million - $2.09 Million	28,805 New	28,805 $1.9 Million

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.